腹膜透析治疗尿毒症伴大量腹水16例临床分析

目的 探讨腹膜透析治疗尿毒症合并大量腹水的应用价值.方法 对16 例尿毒症合并大量腹水的患者,在内科综合治疗的基础上,给予间歇性腹膜透析（IPD）,1周后转为持续性不卧床腹膜透析（CAPD）.比较患者的体征改善情况,透析方式改变前与治疗6个月后尿素氮（BUN）、血肌酐（Scr）、血红蛋白（Hb） 等指标的变化情况.结果 腹部透析后,患者自觉症状明显好转,浮肿消退,BUN、Scr明显下降,Hb、Alb、Tp 明显上升（P 〈0.01）.结论 对于尿毒症伴大量腹水患者的治疗,腹膜透析经济性与安全性突出.

Approach on the Effect of Peritoneal Dialysis in the Treatment of 16 Patients with Uremia and Mass Ascites

Objective To investigate the effect of peritoneal dialysis in the treatment of patients with mass ascites.Methods 16 patients with Uremia and mass ascites received internal medicine therapy combined with intermittent peritoneal dialysis(IPD),and then continuous ambulatory peritoneal dialysis(CAPD) after a week.The subjective symptom and edema were observed,and biochemistry of ascites,BUN,Scr,Hb before changing modes of dialysis and 6 months after treatment were determined.Results After peritoneal dialysis,the subjective symptoms of all patients got better obviously,BUN,Scr decreased obviously,and Hb,Alb,Tp increased significantly(P <0.01).Conclusion Peritoneal dialysis was the effective treatment for patients with Uremia and mass ascites.